About
Capcyte Biotherapeutics develops patented surface modification technology that enhances the biocompatibility and regenerative capacity of cardiovascular implants by selectively capturing and activating progenitor cells, and accelerates the isolation and expansion of therapeutic cells in vitro.
Explore Capcyte Biotherapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.